Meeting
2017 ASCO Annual Meeting
Type, intensity, and duration of chemotherapy (CHT) and their correlation with prognosis of localized soft tissue Ewing tumors (STET): Experience of the Cooperative Weichteilsarkomstudiengruppe (CWS).
Authors
Ewa Koscielniak
Klinikum Stuttgart Olgahospital, Stuttgart, Germany
Ewa Koscielniak , Monika Scheer , Monika Sparber-Sauer , Erika Hallmen , Ivo Leuschner , Bernarda Kazanowska , Gustaf Ljungman , Felix Niggli , Ruth Ladenstein , Stefan S. Bielack , Marc W. Muenter , Thekla von Kalle , Simone Feuchtgruber , Thomas Klingebiel
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Pediatric Oncology
Track
Pediatric Oncology
Sub Track
Pediatric Solid Tumors
Citation
J Clin Oncol 35, 2017 (suppl; abstr 10527)
DOI
10.1200/JCO.2017.35.15_suppl.10527
Abstract #
10527
Poster Bd #
284
Abstract Disclosures
Similar Posters
Poster
2012 ASCO Annual Meeting
Intensive alternating 6-drug chemotherapy for high-risk nonmetastatic rhabdomyosarcoma in children and adolescents: Impact on survival.
First Author: Gerges Attia Demian
Poster
2022 ASCO Annual Meeting
Dose intensity and outcomes of VDC/IE chemotherapy for adolescent and adult patients with Ewing’s family sarcoma.
First Author: Danielle Klingberg
Poster
2022 ASCO Annual Meeting
Risk-adapted local therapy and intensive chemotherapy in patients with high-risk rhabdomyosarcoma.
First Author: Michael W. Bishop
Poster
2021 ASCO Annual Meeting
Comparison of treatment effect and long-term outcomes for pediatric and adult Ewing sarcoma patients in British Columbia, Canada.
First Author: Omar Hajjaj